跳至主要内容
临床试验/CTRI/2023/11/059698
CTRI/2023/11/059698尚未招募2 期

A clinical study to determine the efficacy of Amritadya Guggulu and Haritaki Churna in the management of Medoroga w.s.r to Dyslipidemia . ? - Nil

Prof Anjana Mishra0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients who present with signs and symptoms of medoroga
  • Patients having serum cholesterol 200 to 300mg/dl, s. Triglycerides 150 to 350 mg/dl, S. LDL 100 to 200 mg/dl, S. VLDL 30 TO 100 mg/dl and S. HDL 20 to 40 mg/dl

排除标准

  • Patients having past history of Myocardial infarction, unstable angina, congestive cardiac failure and cerebro vascular accident.
  • Patients having past illness like carcinoma, renal and liver disorders
  • Pregnant females and lactating mother

研究者

发起方
Prof Anjana Mishra

相似试验